Table 2 PD-L1 expression in FFPE RMS tissues, derived cell lines and cytoblocks
From: PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study
ID # | Cell line | Fusion Trascript | PD-L1 (IHC) | Flow Cytometry | PD-L1 (IHC) | |
|---|---|---|---|---|---|---|
| Â | FFPE tissue | DERIVED CELL LINE | CYTOBLOCK (cell line) | |||
TC score | IC score | % TC | Â | |||
RMS12 | RMS-GD | PAX7-FOXO1 | 0 | 2 | 2,10% | 0 |
RMS13 | RMS-ME | PAX7-FOXO1 | 0 | 3 | 1,93% | 0 |
RMS14 | RMS-GJ | PAX3-FOXO1 | 0 | 0 | 5,55% | 0 |
RMS15 | RMS-SG | negative | 0 | 2 | 2,83% | 0 |
RMS16 | RMS-BI | PAX3-FOXO1 | 0 | 3 | 12,25% | 1–5 TC |